SCARNA10: A Potential Drug Target and Biomarker for Small Cajal Body-Specific RNA 10

Target Name: SCARNA10

NCBI ID: G692148

SCARNA10

Other Name(s): Small Cajal body-specific RNA 10 | U85 | MBI | small Cajal body-specific RNA 10 | lnc

SCARNA10: A Potential Drug Target and Biomarker for Small Cajal Body-Specific RNA 10

Small Cajal body-specific RNA 10 (SCARNA10) is a non-coding RNA molecule that has been identified in various organisms, including humans. It plays a crucial role in the development and maintenance of tissues, including muscle and heart cells. SCARNA10 has been shown to be involved in various cellular processes, including cell growth, apoptosis, and inflammation. As a result, it has potential as a drug target or biomarker.

Potential Drug Target

SCARNA10 has been identified as a potential drug target due to its involvement in various cellular processes that are associated with various diseases. For example, studies have shown that SCARNA10 is involved in the regulation of cell apoptosis, which is the process by which cells die naturally.

Research has also shown that SCARNA10 is involved in the regulation of cell proliferation, which is the process by which cells grow and divide. This is important because uncontrolled cell proliferation can lead to the formation of cancerous tumors.

In addition, SCARNA10 has been shown to be involved in the regulation of immune cells, which play a crucial role in fighting off infections and diseases. This is important because immune system disorders, such as cancer, are a leading cause of death in humans.

Potential Biomarker

SCARNA10 has also been identified as a potential biomarker for various diseases. For example, studies have shown that SCARNA10 is downregulated in various diseases, including cancer, heart disease, and neurological disorders. This suggests that SCARNA10 may be a useful biomarker for these diseases.

In addition, SCARNA10 has been shown to be involved in the regulation of cellular processes that are associated with various diseases. For example, studies have shown that SCARNA10 is involved in the regulation of blood clotting, which is important for maintaining blood flow to the body's tissues.

Conclusion

In conclusion, SCARNA10 is a non-coding RNA molecule that has been identified in various organisms, including humans. It plays a crucial role in the development and maintenance of tissues, including muscle and heart cells. SCARNA10 has potential as a drug target or biomarker due to its involvement in various cellular processes that are associated with various diseases. Further research is needed to fully understand the role of SCARNA10 in these processes and to develop effective treatments for diseases associated with it.

Protein Name: Small Cajal Body-specific RNA 10

The "SCARNA10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCARNA10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets